Peptide directoryReproductive

Inhibin A

The dominant follicle’s signal to switch FSH off, and a pregnancy-screen marker.

Where it comes from

Made in
Granulosa cells of the dominant follicle, the corpus luteum, and the placenta
Sent out by
Peaks at mid-cycle and in the luteal phase; high through pregnancy
Acts on
  • Pituitary gonadotrophs (FSH)
  • Ovary (local)

What it does

  • Shuts off FSH once a follicle has been chosen, so only one ovulates
  • Its fall is one of the earliest signs of reproductive ageing, before FSH rises 1
  • A readout of corpus luteum and placenta rather than a target for treatment

In medicine

  • The fourth marker of the second-trimester quadruple screen, where it is raised in Down syndrome; the four markers together found 81 per cent of cases at a 5 per cent false-positive rate 2
  • A tumour marker for granulosa cell tumours of the ovary: in the first series, it was already raised 5 and 20 months before a recurrence showed itself 3
  • Low in early pregnancy failure, alongside hCG and progesterone

Beyond the body’s own use

  • Nothing is given as inhibin A and nothing blocks it in particular. The activin traps approved for anaemia and for pulmonary hypertension work on the other side of the same system
  • Its screening job is being displaced by cell-free DNA testing, which reads fetal chromosomes directly, so the quadruple screen is now the second line where DNA testing is not available

Sources

  1. Welt et al., Female reproductive aging is marked by decreased secretion of dimeric inhibin, Journal of Clinical Endocrinology and Metabolism 1999
  2. Malone et al., First-trimester or second-trimester screening, or both, for Down’s syndrome, New England Journal of Medicine 2005
  3. Lappöhn et al., Inhibin as a marker for granulosa-cell tumors, New England Journal of Medicine 1989

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.